Monitoring of Babies' Heart Rates During Labour Using Mobile Monitors

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The study has been designed as a prospective, non-randomised, single centre study to determine the predictive utility of Short Term Variation (STV) of the Fetal Heart Rate (FHR)from the intrapartum FHR data collected using the portable fetal ECG monitor (Monica AN24) in women requiring continuous monitoring during labour due to antenatal or intrapartum risk factors.

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT05147584` - Trans-abdominal Fetal Pulse Oximetry	N/A
	Completed	`NCT05921955` - Application of High-flow Nasal Oxygen in Cesarean Section	N/A

NCT number	NCT03922854
Study type	Observational
Source	Sheffield Teaching Hospitals NHS Foundation Trust
Contact
Status	Completed
Phase
Start date	January 10, 2018
Completion date	December 31, 2019

Monitoring of Babies' Heart Rates During Labour Using Mobile Monitors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms